Two reduced phosphomolybdate hybrid assemblies modified by Cu-biz and/or Cu-bdz complexes for photocatalytic and bifunctional electrocatalytic activities

Exploration of the Potential Role of Serum Albumin in the Delivery of Cu(I) to Ctr1

Human serum albumin (HSA) is the major copper (Cu) carrier in blood. The majority of previous studies that have investigated Cu interactions with HSA have focused primarily on the Cu(II) oxidation state. Yet, cellular Cu uptake by the human copper transport protein (Ctr1), a plasma membrane-embedded protein responsible for Cu uptake into cells, requires Cu(I). Recent in vitro work has determined that reducing agents, such as the ascorbate present in blood, are sufficient to reduce the Cu(II)HSA complex to form Cu(I)HSA and that Cu(I) is bound to HSA with pM affinity. The biological accessibility of Cu(I)HSA suggests that HSA-bound Cu(I) may be an unappreciated form of Cu cargo and a key player in extracellular Cu trafficking. To better understand Cu trafficking by HSA, we sought to investigate the exchange of Cu(I) from HSA to a model peptide of the Cu-binding ectodomain of Ctr1. In this study, we used X-ray absorption near-edge spectroscopy to show that Cu(I) becomes more highly coordinated as increasing amounts of the Ctr_1-14 model peptide are added to a solution of Cu(I)HSA. Extended X-ray absorption fine structure (EXAFS) spectroscopy was used to further characterize the interaction of Cu(I)HSA with Ctr_1-14 by determining the ligands coordinating Cu(I) and their bond lengths. The EXAFS data support that some Cu(I) likely undergoes complete transfer from HSA to Ctr_1-14. This finding of HSA interacting with and releasing Cu(I) to an ectodomain model peptide of Ctr1 suggests a mechanism by which HSA delivers Cu(I) to cells under physiological conditions.

Porous {P6Mo18O73}-type Poly(oxometalate) Metal-Organic Frameworks for Improved Pseudocapacitance and Electrochemical Sensing Performance

{P₆Mo₁₈} poly(oxometalate) (POM) clusters have huge steric hindrance and limited active oxygen atoms, which make them difficult to combine with metal-organic units to form three-dimensional (3D) porous structures. Therefore, functionalization of such POMs has always been a bottleneck that is difficult to break through. In this study, {P₆Mo₁₈} POM was successfully grafted on a lock-like metal-organic chain to generate a multiporous coordination polymer, [{Na(H₂O)(H₂btb)}{Cu₄^I(H₂O)(pz)₅Cl}{H₂Sr⊂P₆Mo₂^VMo₁₆^VIO₇₃}]·3H₂O (1) (pz = pyrazine; btb = 1,4-bis(1,2,4-triazole) butane). Meanwhile, a zero-dimensional (0-D) control compound with only btb ligands as counterions, (H₄btb)[H₄Sr⊂P₆Mo₂^VMo₁₆^VIO₇₃]·3H₂O (2), was also obtained via a hydrothermal reaction. Compound 1 represents the first basket-type 3D poly(oxometalate) metal-organic framework (POMOF) assembly, which possesses interpenetrating pores and complex topology. 1-GO-CPE displays improved supercapacitor (SC) performance (the specific capacitance of 929.4 F g^-1 at a current density of 3 A g^-1 with 94.1% of cycle efficiency after 5000 cycles) compared with 2-GO-CPE and most reported POMOF electrode materials, which may be due to the outstanding redox capability of basket-POM, introduction of metal-organic chains, intersecting pores, and excellent conductivity of graphene. An asymmetric SC device with 1-GO-CPE as the negative electrode exhibits an energy density of 29.7 Wh kg^-1 with a power density of 3148.2 W kg^-1 and long-lasting cycling life. In addition, 1-GO-GCE as an electrochemical sensor responds to dopamine (DA) at a voltage of 0.40 V and shows lower detection limits (0.19 μM (signal-to-noise ratio (SNR) = 3)), higher selectivity, and good reproducibility in the linear range of 0.56 μM to 0.24 mM. The ability to accurately detect the content of DA in biological samples further proves the feasibility of the sensor in practical applications.